Vitamin D3 Injectable Recalled Due to Sterility Assurance Issues
Olympia Compounding Pharmacy is recalling Vitamin D3 injectable vials due to lack of sterility assurance. A total of 3,083 vials were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for an injectable pharmaceutical product with unassured sterility. While no illnesses or injuries have been reported, failure to meet sterility standards in an injectable product poses significant risk of infection and serious adverse health consequences if contaminated product is administered.
Plain-English summary
Olympia Compounding Pharmacy is recalling Vitamin D3 (50,000 IU/mL) Multi-Dose 30 mL injectable vials. The affected product is supplied as a prescription-only medication with NDC 73198-0075-30, manufactured by Olympia Compounding Pharmacy located at 6700 Conroy Road, Suite 155, Orlando, Florida 32835.
The recall was issued because the manufacturer cannot assure that the product meets sterility standards. Injectable pharmaceutical products must be sterile to prevent patient infection and serious health complications.
A total of 3,083 vials were distributed nationwide, including to Puerto Rico and the US Virgin Islands. The affected lot numbers are L24009 (with a beyond-use date of June 9, 2022) and L24028 (with a beyond-use date of June 28, 2022). Healthcare providers and patients who have received this product should stop use immediately and consult with their healthcare provider about alternative treatment options.
The recalled product
- Product
- Vitamin D3 (50,000 IU/mL)Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0075-30
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: L24009 BUD: 6/9/2022
- L24028 BUD: 6/28/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27